Akwel SA
PAR:AKW
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Akwel SA
PAR:AKW
|
FR |
|
S
|
Stolt-Nielsen Ltd
LSE:0OHK
|
UK |
|
Moderna Inc
NASDAQ:MRNA
|
US |
|
Fortec Elektronik AG
XETRA:FEV
|
DE |
|
V-ZUG Holding AG
SIX:VZUG
|
CH |
|
Persimmon PLC
LSE:PSN
|
UK |
|
N
|
Nur Ink Innovations Ltd
TASE:NURI
|
IL |
|
Z
|
Zalando SE
OTC:ZLDSF
|
DE |
Balance Sheet
Balance Sheet Decomposition
Akwel SA
Akwel SA
Balance Sheet
Akwel SA
| Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
10
|
5
|
8
|
6
|
6
|
5
|
4
|
5
|
11
|
21
|
17
|
20
|
40
|
59
|
68
|
115
|
108
|
93
|
105
|
175
|
167
|
167
|
152
|
150
|
|
| Cash Equivalents |
10
|
5
|
8
|
6
|
6
|
5
|
4
|
5
|
11
|
21
|
17
|
20
|
40
|
59
|
68
|
115
|
108
|
93
|
105
|
175
|
167
|
167
|
152
|
150
|
|
| Total Receivables |
159
|
191
|
148
|
132
|
128
|
125
|
134
|
90
|
80
|
84
|
133
|
131
|
120
|
139
|
174
|
194
|
209
|
229
|
233
|
234
|
191
|
224
|
193
|
168
|
|
| Accounts Receivables |
135
|
181
|
137
|
124
|
115
|
114
|
119
|
71
|
76
|
80
|
116
|
111
|
102
|
116
|
138
|
156
|
175
|
183
|
188
|
186
|
150
|
156
|
166
|
143
|
|
| Other Receivables |
24
|
10
|
11
|
8
|
13
|
11
|
14
|
19
|
4
|
4
|
17
|
21
|
18
|
23
|
36
|
39
|
34
|
45
|
46
|
48
|
41
|
68
|
27
|
25
|
|
| Inventory |
62
|
48
|
40
|
40
|
47
|
54
|
60
|
44
|
34
|
33
|
58
|
60
|
57
|
64
|
86
|
99
|
125
|
137
|
146
|
128
|
130
|
157
|
173
|
142
|
|
| Other Current Assets |
11
|
7
|
1
|
1
|
1
|
1
|
0
|
0
|
4
|
4
|
3
|
5
|
3
|
4
|
4
|
5
|
6
|
5
|
21
|
32
|
33
|
33
|
33
|
38
|
|
| Total Current Assets |
242
|
250
|
198
|
179
|
181
|
185
|
198
|
139
|
128
|
143
|
212
|
216
|
220
|
267
|
332
|
413
|
448
|
463
|
505
|
570
|
521
|
547
|
551
|
498
|
|
| PP&E Net |
71
|
59
|
52
|
49
|
88
|
88
|
93
|
89
|
82
|
78
|
113
|
126
|
126
|
158
|
180
|
201
|
245
|
284
|
306
|
280
|
265
|
266
|
284
|
286
|
|
| PP&E Gross |
71
|
59
|
52
|
49
|
88
|
88
|
93
|
89
|
82
|
78
|
113
|
126
|
126
|
158
|
180
|
201
|
245
|
284
|
306
|
280
|
265
|
266
|
284
|
286
|
|
| Accumulated Depreciation |
127
|
138
|
145
|
150
|
128
|
137
|
143
|
150
|
161
|
167
|
191
|
229
|
241
|
277
|
298
|
317
|
332
|
357
|
389
|
418
|
453
|
482
|
488
|
521
|
|
| Intangible Assets |
3
|
1
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
2
|
2
|
2
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
|
| Goodwill |
14
|
12
|
8
|
6
|
8
|
8
|
8
|
8
|
8
|
8
|
32
|
31
|
30
|
52
|
55
|
55
|
52
|
47
|
45
|
36
|
35
|
36
|
35
|
35
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Long-Term Investments |
1
|
2
|
2
|
2
|
1
|
1
|
2
|
3
|
2
|
2
|
3
|
5
|
3
|
4
|
3
|
1
|
1
|
3
|
2
|
2
|
2
|
4
|
2
|
2
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
3
|
3
|
8
|
8
|
7
|
9
|
9
|
7
|
6
|
7
|
6
|
10
|
12
|
|
| Other Assets |
14
|
12
|
8
|
6
|
8
|
8
|
8
|
8
|
8
|
8
|
32
|
31
|
30
|
52
|
55
|
55
|
52
|
47
|
45
|
36
|
35
|
36
|
35
|
35
|
|
| Total Assets |
331
N/A
|
323
-2%
|
259
-20%
|
236
-9%
|
279
+18%
|
283
+1%
|
301
+6%
|
238
-21%
|
221
-7%
|
231
+5%
|
365
+58%
|
384
+5%
|
383
0%
|
489
+28%
|
581
+19%
|
680
+17%
|
755
+11%
|
807
+7%
|
865
+7%
|
894
+3%
|
830
-7%
|
860
+4%
|
883
+3%
|
836
-5%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
108
|
120
|
99
|
93
|
87
|
89
|
97
|
49
|
53
|
56
|
81
|
79
|
63
|
73
|
93
|
104
|
122
|
121
|
117
|
117
|
82
|
112
|
110
|
85
|
|
| Accrued Liabilities |
15
|
20
|
24
|
23
|
20
|
15
|
18
|
24
|
19
|
19
|
31
|
34
|
27
|
39
|
38
|
36
|
38
|
39
|
43
|
43
|
36
|
37
|
36
|
40
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
47
|
64
|
49
|
20
|
29
|
36
|
43
|
48
|
15
|
10
|
37
|
23
|
22
|
26
|
33
|
38
|
47
|
47
|
65
|
75
|
43
|
37
|
35
|
4
|
|
| Other Current Liabilities |
33
|
13
|
5
|
4
|
4
|
8
|
7
|
0
|
6
|
3
|
6
|
6
|
5
|
13
|
24
|
35
|
32
|
44
|
20
|
25
|
18
|
47
|
16
|
12
|
|
| Total Current Liabilities |
203
|
217
|
176
|
139
|
140
|
148
|
165
|
120
|
92
|
88
|
155
|
142
|
118
|
151
|
188
|
212
|
239
|
251
|
245
|
260
|
179
|
196
|
197
|
142
|
|
| Long-Term Debt |
64
|
50
|
23
|
29
|
35
|
27
|
25
|
22
|
20
|
11
|
49
|
57
|
57
|
97
|
91
|
90
|
87
|
86
|
75
|
39
|
26
|
17
|
11
|
13
|
|
| Deferred Income Tax |
0
|
4
|
3
|
2
|
12
|
13
|
12
|
11
|
11
|
10
|
10
|
10
|
8
|
4
|
6
|
3
|
6
|
5
|
7
|
9
|
7
|
6
|
6
|
10
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
|
| Other Liabilities |
11
|
6
|
8
|
9
|
7
|
10
|
9
|
9
|
8
|
10
|
13
|
13
|
15
|
10
|
11
|
11
|
14
|
10
|
30
|
46
|
47
|
49
|
58
|
64
|
|
| Total Liabilities |
278
N/A
|
277
0%
|
209
-25%
|
179
-14%
|
194
+8%
|
198
+2%
|
211
+7%
|
162
-23%
|
130
-20%
|
118
-9%
|
226
+92%
|
223
-2%
|
198
-11%
|
263
+33%
|
296
+12%
|
318
+7%
|
346
+9%
|
354
+2%
|
359
+1%
|
355
-1%
|
260
-27%
|
268
+3%
|
273
+2%
|
230
-16%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
21
|
21
|
21
|
21
|
21
|
21
|
21
|
21
|
21
|
21
|
21
|
21
|
21
|
21
|
21
|
21
|
21
|
21
|
21
|
21
|
19
|
21
|
21
|
21
|
|
| Retained Earnings |
32
|
24
|
29
|
35
|
60
|
61
|
66
|
52
|
67
|
89
|
115
|
137
|
161
|
202
|
261
|
338
|
386
|
429
|
482
|
516
|
549
|
569
|
587
|
579
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
4
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Equity |
53
N/A
|
46
-13%
|
50
+10%
|
56
+12%
|
85
+51%
|
85
0%
|
89
+6%
|
76
-15%
|
90
+19%
|
113
+25%
|
139
+22%
|
161
+16%
|
185
+15%
|
226
+22%
|
285
+26%
|
362
+27%
|
409
+13%
|
453
+11%
|
506
+12%
|
540
+7%
|
570
+6%
|
592
+4%
|
610
+3%
|
607
-1%
|
|
| Total Liabilities & Equity |
331
N/A
|
323
-2%
|
259
-20%
|
236
-9%
|
279
+18%
|
283
+1%
|
301
+6%
|
238
-21%
|
221
-7%
|
231
+5%
|
365
+58%
|
384
+5%
|
383
0%
|
489
+28%
|
581
+19%
|
680
+17%
|
755
+11%
|
807
+7%
|
865
+7%
|
894
+3%
|
830
-7%
|
860
+4%
|
883
+3%
|
836
-5%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
27
|
26
|
26
|
26
|
27
|
27
|
27
|
27
|
27
|
27
|
27
|
27
|
27
|
27
|
27
|
27
|
27
|
27
|
27
|
27
|
27
|
27
|
27
|
27
|
|